title: Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response.
abstract: Besides exerting its own lipolytic effect, growth hormone (GH) has been reported to potentiate the lipolytic response of adipose tissue to epinephrine. It was thought interesting to find out whether long-term recombinant human growth hormone (rhGH) administration modifies epinephrine-induced lipolysis in isolated adipocytes of GH-deficient adults. In a double-blind protocol, GH-deficient subjects received either 6 mo placebo (controls, n = 5) or 6 mo rhGH (treated, n = 5). Biopsies of fat were obtained from the periumbilical region before and after placebo or rhGH administration. The response of the collagenase-isolated fat cells to various concentrations of epinephrine was assessed by glycerol release, measured by bioluminescence. Epinephrine-induced lipolysis was not altered by 6 mo placebo, while it was significantly increased by 6 mo rhGH. A similar response was obtained with isoproterenol, but no significant differences occurred in either group with UK 14304, an alpha 2-adrenoreceptor agonist. Thus, in GH-deficient adults, long-term rhGH administration improves the lipolytic response of isolated adipocytes to epinephrine, essentially by increasing the efficiency of the beta-adrenergic pathway.
authors.affiliation: Laboratoire de Physiologie, Faculté de Médecine Toulouse-Purpan, France.
authors.forename: M
authors.initials: M
authors.lastname: Beauville
authors.forename: I
authors.initials: I
authors.lastname: Harant
authors.forename: F
authors.initials: F
authors.lastname: Crampes
authors.forename: D
authors.initials: D
authors.lastname: Riviere
authors.forename: M T
authors.initials: MT
authors.lastname: Tauber
authors.forename: J P
authors.initials: JP
authors.lastname: Tauber
authors.forename: M
authors.initials: M
authors.lastname: Garrigues
mesh_terms: D000243:Adenosine Deaminase / Q000494:pharmacology; D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism*; D000328:Adult; D000068438:Brimonidine Tartrate; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000378:metabolism*; D005260:Female; D013006:Growth Hormone / Q000172:deficiency / Q000494:pharmacology*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects; D008297:Male; D011810:Quinoxalines / Q000494:pharmacology; D011994:Recombinant Proteins
chemical_list: D011810:Quinoxalines; D011994:Recombinant Proteins; D000068438:Brimonidine Tartrate; D013006:Growth Hormone; D000243:Adenosine Deaminase; D007545:Isoproterenol; D004837:Epinephrine